Patents by Inventor David Nanus

David Nanus has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20020183388
    Abstract: The present invention provides a method of inhibiting growth of solid tumors in an animal which comprises administering an effective amount of trichostatin A (TSA) to an animal in need of such treatment. The present invention also provides a method of inhibiting growth of solid tumors in an animal which comprises administering an effective amount of a histone deacetylase inhibitor and a retinoid to an animal in need of such treatment. Examples of solid tumors which may be treated using the methods of the invention include but are not limited to carcinomas of the head and neck, breast, skin, kidney, oral cavity, colon, prostate, pancreas and lung.
    Type: Application
    Filed: February 1, 2002
    Publication date: December 5, 2002
    Inventors: Lorraine J. Gudas, David Nanus
  • Publication number: 20020001615
    Abstract: Alfa interferon (&agr;-IFN or alpha-interferon) and liposomal all-trans retinoic acid is useful in cancer treatment with particular reference to renal cancer. Optionally, a regimen of &agr;-interferon from about 3 to about 5 million units sc daily and liposomal all-trans retinoic acid at from about 15 mg/m2 to about 90 mg/m2, or about 140 mg/m2, or about 300 mg/m2 or more. Dosage periodicity of about three times per week for both drugs in about 8 week cycles is useful.
    Type: Application
    Filed: March 16, 2001
    Publication date: January 3, 2002
    Applicant: Aronex Pharmaceuticals, Inc.
    Inventor: David Nanus